Non-Small Cell Lung Cancer Coverage from Every Angle
Advertisement
Advertisement

Tony Mok, MD, on Oncogene-Addicted NSCLC: Expert Perspective on the Challenges

Posted: Monday, September 11, 2017

Tony Mok, MD, of the Chinese University of Hong Kong, discusses new drivers in this disease setting as well as strategies against mechanisms of resistance and the role of immunotherapy.



By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.